Entrada Therapeutics Inc (TRDA)
18.70
+0.65
(+3.60%)
USD |
NASDAQ |
Nov 22, 11:52
Entrada Therapeutics Shareholders Equity (Quarterly): 422.45M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 422.45M |
| June 30, 2024 | 429.92M |
| March 31, 2024 | 269.37M |
| December 31, 2023 | 242.36M |
| September 30, 2023 | 246.66M |
| June 30, 2023 | 206.91M |
| March 31, 2023 | 229.61M |
| December 31, 2022 | 212.55M |
| Date | Value |
|---|---|
| September 30, 2022 | 233.22M |
| June 30, 2022 | 256.04M |
| March 31, 2022 | 277.39M |
| December 31, 2021 | 298.72M |
| September 30, 2021 | -72.59M |
| June 30, 2021 | -59.01M |
| December 31, 2020 | -41.49M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-72.59M
Minimum
Sep 2021
429.92M
Maximum
Jun 2024
210.14M
Average
242.36M
Median
Dec 2023
Shareholders Equity (Quarterly) Benchmarks
| Catalyst Pharmaceuticals Inc | 660.94M |
| Vertex Pharmaceuticals Inc | 15.63B |
| Assembly Biosciences Inc | 26.00M |
| Sarepta Therapeutics Inc | 1.221B |
| Regenxbio Inc | 301.42M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 554.59M |
| Total Liabilities (Quarterly) | 132.14M |
| Current Ratio | 6.591 |